Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2501635122
Affiliations:
10
Authors:
25
Go to article
Institutions Authors Share
Genentech, Inc., United States of America (USA)
25.000000
25.000000
25.000000
 1.00
Interested in Pharmacology and Pharmaceutical Sciences?